116 related articles for article (PubMed ID: 25745998)
1. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.
Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK
Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998
[TBL] [Abstract][Full Text] [Related]
2. RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer.
Khare V; Tabassum S; Chatterjee U; Chatterjee S; Ghosh MK
J Exp Clin Cancer Res; 2019 Jul; 38(1):330. PubMed ID: 31351496
[TBL] [Abstract][Full Text] [Related]
3. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.
Chen J; Gomes AR; Monteiro LJ; Wong SY; Wu LH; Ng TT; Karadedou CT; Millour J; Ip YC; Cheung YN; Sunters A; Chan KY; Lam EW; Khoo US
PLoS One; 2010 Aug; 5(8):e12293. PubMed ID: 20808831
[TBL] [Abstract][Full Text] [Related]
4. The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor.
Bates GJ; Nicol SM; Wilson BJ; Jacobs AM; Bourdon JC; Wardrop J; Gregory DJ; Lane DP; Perkins ND; Fuller-Pace FV
EMBO J; 2005 Feb; 24(3):543-53. PubMed ID: 15660129
[TBL] [Abstract][Full Text] [Related]
5. The antiproliferative and apoptotic effects of sirtinol, a sirtuin inhibitor on human lung cancer cells by modulating Akt/β-catenin-Foxo3a axis.
Fong Y; Lin YC; Wu CY; Wang HM; Lin LL; Chou HL; Teng YN; Yuan SS; Chiu CC
ScientificWorldJournal; 2014; 2014():937051. PubMed ID: 25184156
[TBL] [Abstract][Full Text] [Related]
6. Natural bioactive compounds and FOXO3a in cancer therapeutics: An update.
Manoharan S; Prajapati K; Perumal E
Fitoterapia; 2024 Mar; 173():105807. PubMed ID: 38168566
[TBL] [Abstract][Full Text] [Related]
7. Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer.
Liu J; Duan Z; Guo W; Zeng L; Wu Y; Chen Y; Tai F; Wang Y; Lin Y; Zhang Q; He Y; Deng J; Stewart RL; Wang C; Lin PC; Ghaffari S; Evers BM; Liu S; Zhou MM; Zhou BP; Shi J
Nat Commun; 2018 Dec; 9(1):5200. PubMed ID: 30518851
[TBL] [Abstract][Full Text] [Related]
8. Structure and expression of the human p68 RNA helicase gene.
Rössler OG; Hloch P; Schütz N; Weitzenegger T; Stahl H
Nucleic Acids Res; 2000 Feb; 28(4):932-9. PubMed ID: 10648785
[TBL] [Abstract][Full Text] [Related]
9. FOXO3a functions as a transcriptional and co-transcriptional splicing regulator in vascular endothelial cell lines.
Abudureyimu S; He C; Xie W; Chen Z; Airikenjiang H; Abulaiti D; Cao Y; Qiu H; Gao Y
Gene; 2024 Apr; 904():148221. PubMed ID: 38286271
[TBL] [Abstract][Full Text] [Related]
10. The Drosophila P68 RNA helicase regulates transcriptional deactivation by promoting RNA release from chromatin.
Buszczak M; Spradling AC
Genes Dev; 2006 Apr; 20(8):977-89. PubMed ID: 16598038
[TBL] [Abstract][Full Text] [Related]
11. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
12. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.
Jacob J; Favicchio R; Karimian N; Mehrabi M; Harding V; Castellano L; Stebbing J; Giamas G
Cancer Lett; 2016 Mar; 372(1):137-46. PubMed ID: 26739063
[TBL] [Abstract][Full Text] [Related]
13. Unwinding the mechanisms of a DEAD-box RNA helicase in cancer.
Russell R
J Mol Biol; 2015 May; 427(9):1797-800. PubMed ID: 25836982
[No Abstract] [Full Text] [Related]
14. Blood brain barrier: a challenge for effectual therapy of brain tumors.
Bhowmik A; Khan R; Ghosh MK
Biomed Res Int; 2015; 2015():320941. PubMed ID: 25866775
[TBL] [Abstract][Full Text] [Related]
15. Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling.
Motiño O; Francés DE; Mayoral R; Castro-Sánchez L; Fernández-Velasco M; Boscá L; García-Monzón C; Brea R; Casado M; Agra N; Martín-Sanz P
Mol Cell Biol; 2015 Jul; 35(14):2554-67. PubMed ID: 25963660
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of the p300-p53 interplay by DDX24.
Shi D; Dai C; Qin J; Gu W
Oncogene; 2016 Jan; 35(4):528-36. PubMed ID: 25867071
[TBL] [Abstract][Full Text] [Related]
17. Protective Role of RNA Helicase DEAD-Box Protein 5 in Smooth Muscle Cell Proliferation and Vascular Remodeling.
Fan Y; Chen Y; Zhang J; Yang F; Hu Y; Zhang L; Zeng C; Xu Q
Circ Res; 2019 May; 124(10):e84-e100. PubMed ID: 30879402
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer.
Taniguchi T; Iizumi Y; Watanabe M; Masuda M; Morita M; Aono Y; Toriyama S; Oishi M; Goi W; Sakai T
Cell Death Dis; 2016 May; 7(5):e2211. PubMed ID: 27148684
[TBL] [Abstract][Full Text] [Related]
19. The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.
Sarkar M; Khare V; Ghosh MK
Oncogene; 2017 Jun; 36(22):3080-3093. PubMed ID: 27941883
[TBL] [Abstract][Full Text] [Related]
20. Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin.
Liu C; Wang L; Jiang Q; Zhang J; Zhu L; Lin L; Jiang H; Lin D; Xiao Y; Fang W; Guo S
Front Oncol; 2019; 9():211. PubMed ID: 31032220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
